BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 15, 2026
Home » Authors » Holland Johnson

Articles by Holland Johnson

Deals roundup: BC to buy Olympus lab-based diagnostics unit for $800M

March 2, 2009
By Holland Johnson

Various causes and companies espoused at kickoff conference

March 1, 2009
By Holland Johnson

Equity firm adds Pelak to mine med-tech window of opportunity

Feb. 23, 2009
By Holland Johnson

Private companies continue to draw value-minded investors

Jan. 22, 2009
By Holland Johnson

Dimon argues for some form of universal healthcare in the U.S.

Jan. 22, 2009
By Holland Johnson

Attendees at meeting enjoy its targeted, intimate setting

Jan. 20, 2009
By Holland Johnson
SAN FRANCISCO – While much of the action in town last week was down the street at the packed J.P. Morgan Healthcare conference, only a block up Powell Street at the Sir Francis Drake Hotel, the OneMedPlace Finance Forum gave attendees a glimpse at some private and smaller public companies that are on the cutting edge of medicine, and in a much more intimate setting. (Medical Device Daily)
Read More

Private companies seek 'ayes' from investment community

Jan. 16, 2009
By Holland Johnson
SAN FRANCISCO – While larger companies at the J.P. Morgan Healthcare Conference have their fans, it is the smaller private companies that really pique the interest of many investors with their potential for developing dynamic new products and, hopefully, to get in on a good thing early. (Medical Device Daily)
Read More

Gathering allows firms of all sizes to make their pitch

Jan. 15, 2009
By Holland Johnson

Dimon argues for some form of universal healthcare in the U.S.

Jan. 14, 2009
By Holland Johnson
SAN FRANCISCO – The deepening recession did not appear to dampen attendees' enthusiasm for the healthcare sector here at the JP Morgan conference, nor did it serve to thin out the crowds at the Westin St. Francis, which seemed to be even larger than ever. Most of the throng gathered to hear JP Morgan Chairman/CEO Jamie Dimon speak on a variety of topics including healthcare policy and the current state of the economy. (Medical Device Daily)
Read More

Dimon Argues for Some Form of Universal Health Care in U.S.

Jan. 14, 2009
By Holland Johnson
Previous 1 2 … 34 35 36 37 38 39 40 41 42 … 87 88 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 15, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 15, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing